Squamous Cell Carcinoma

Adjuvant cemiplimab prolonged DFS compared with placebo for certain patients with cutaneous squamous cell carcinoma, according to the agent’s manufacturer.

The addition of adjuvant nivolumab to standard-of-care radiotherapy and cisplatin improved survival for patients with locally advanced squamous cell carcinoma of the head and neck.

Metformin may have potential in preventing nonmelanoma skin cancer, including in most populations with skin of color, according to a study.

Patients who used dupilumab for atopic dermatitis had significantly lower risks for internal malignancies than patients using other therapies, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

The FDA approved cosibelimab-ipdl for the treatment of certain patients with cutaneous squamous cell carcinoma.

BOSTON — Physicians suspect the solvent used in the administration of pembrolizumab may have triggered recurrent angioedema for a patient with squamous cell carcinoma, according to a poster presented at the CHEST Annual Meeting.

ORLANDO — Topical 5-fluorouracil and calcipotriene proved to be highly effective for superficial keratinocyte carcinomas, according to a presentation at the American Society for Dermatologic Surgery Annual Meeting.

Cemiplimab provided clinically meaningful responses for patients with metastatic and locally advanced cutaneous squamous cell carcinoma, according to a study.

Adults and children with atypical hemolytic uremic syndrome who switched from eculizumab to ravulizumab had stable renal function and hematologic values with similar safety seen in clinical trials, according to data from a registry study.

The DecisionDx-SCC test successfully identified which patients with cutaneous squamous cell carcinoma would most likely benefit from adjuvant radiation therapy, according to a study.